S&P 500

6.084,19

0,82%

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

Startseite
Investieren
Aktien
USA
NASDAQ
Guilford Pharmaceuticals (MM) (GLFD)
Guilford Pharmaceuticals (MM) (GLFD) News

GLFD

Guilford (GLFD)

Guilford Pharmaceuticals (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GLFD

1 2 3 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
30/09/2005	00h27	PR Newswire (US)	Guilford Pharmaceuticals Stockholders Vote to Approve MGI PHARMA Merger	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
01/09/2005	13h00	Business Wire	MGI PHARMA and Guilford Pharmaceuticals Announce Expiration of the Hart-Scott-Rodino Waiting Period	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
08/08/2005	16h11	PR Newswire (US)	Guilford Pharmaceuticals Reports 2005 Second Quarter Results	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
08/08/2005	14h45	PR Newswire (US)	Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
02/08/2005	20h33	PR Newswire (US)	Guilford Pharmaceuticals to Announce Second Quarter 2005 Financial Results on Monday, August 8, 2005	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
24/05/2005	21h44	PR Newswire (US)	Guilford Pharmaceuticals Implements Strategic Reorganization to Align Resources With Corporate Strategy	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
18/05/2005	21h00	PR Newswire (US)	Guilford Pharmaceuticals Presents New NAALADase Inhibitor Data in Chemotherapy-Induced Neuropathy at ASCO	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
17/05/2005	21h39	PR Newswire (US)	Guilford Pharmaceuticals Announces Promising Results at ASCO in Study of Newly Diagnosed High Grade Malignant Glioma	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
11/05/2005	17h01	PR Newswire (US)	AGGRASTAT(R) Injection Strategy Trial Data Published in JAMA	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
09/05/2005	15h42	PR Newswire (US)	Guilford Pharmaceuticals Reports 2005 First Quarter Results	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
09/05/2005	14h45	PR Newswire (US)	Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
02/05/2005	15h00	PR Newswire (US)	Guilford Pharmaceuticals to Announce First Quarter 2005 Financial Results on Monday, May 9, 2005	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
21/04/2005	20h07	PR Newswire (US)	Guilford Pharmaceuticals Restarts AQUAVAN(R) Clinical Development Program	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
06/04/2005	14h45	PR Newswire (US)	Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
05/04/2005	19h31	PR Newswire (US)	Guilford Pharmaceuticals to Host Webcast Outlining New Corporate Strategy	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
24/03/2005	18h04	PR Newswire (US)	Guilford Pharmaceuticals Announces Phase III AQUAVAN(R) Trial Meets Primary Endpoint	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
08/03/2005	17h03	PR Newswire (US)	Guilford Pharmaceuticals: AGGRASTAT(R) Injection Clinical Data Presented at American College of Cardiology Annual Meeting	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
01/03/2005	21h55	PR Newswire (US)	Guilford Pharmaceuticals Reports 2004 Year-End Financial Results	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
01/03/2005	13h45	PR Newswire (US)	Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
10/02/2005	17h42	PR Newswire (US)	Guilford Pharmaceuticals to Announce 2004 Year-End Financial Results on Tuesday, March 1, 2005	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
17/12/2004	23h30	PR Newswire (US)	Guilford Pharmaceuticals Completes Sale and Leaseback and Receives $19.4 Million in Net Proceeds	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
02/12/2004	14h45	PR Newswire (US)	Guilford Pharmaceuticals to Acquire ProQuest Pharmaceuticals; Guilford to Obtain Exclusive Worldwide Ownership of AQUAVAN(R) Pro	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
22/11/2004	15h03	PR Newswire (US)	Guilford Pharmaceuticals Presents New GLIADEL(R) Wafer Data at the Society for Neuro-Oncology Annual Meeting	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
17/11/2004	23h30	PR Newswire (US)	Guilford Pharmaceuticals Announces Equity Compensation Arrangement With Dean J. Mitchell Pursuant to NASDAQ Rules	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
17/11/2004	14h01	PR Newswire (US)	Dean J. Mitchell Appointed President and Chief Executive Officer of Guilford Pharmaceuticals	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
12/11/2004	16h58	PR Newswire (US)	AGGRASTAT(R) Strategy Trial Data Presented At American Heart Association Annual Meeting	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
08/11/2004	18h11	PR Newswire (US)	Guilford Pharmaceuticals Reports 2004 Third Quarter Results	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
05/11/2004	14h30	PR Newswire (US)	Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
27/09/2004	16h33	PR Newswire (US)	Guilford Pharmaceuticals Announces Orphan Drug Designation for GLIADEL(R) Wafer; Market Exclusivity for GLIADEL(R) Extends Until	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)
22/09/2004	16h03	PR Newswire (US)	Guilford to Present at UBS Global Life Sciences Conference	NASDAQ:GLFD	Guilford Pharmaceuticals (MM)